BRIAN COLEMAN: Open Payments
NPI 1861575607 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$116 in 7 payments from 3 companies in 2025. Trend: 2023 $24 · 2024 $55 · 2025 $116
Food & beverage: $116
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $48 |
| Janssen Pharmaceuticals, Inc | 2 | $34 |
| Alkermes, Inc. | 2 | $34 |
Products named: INVEGA SUSTENNA, ARISTADA, ABILIFY MAINTENA, ABILIFY ASIMTUFII.
Industry payments across WA — which companies pay providers there.
